Cargando…

Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis

BACKGROUND: Corpus callosotomy (CC) is appropriate for patients with seizures of a bilateral or diffuse origin, or those with seizures of a unilateral origin with rapid spread to the contralateral cerebral hemisphere. The efficiency of CC in patients with drug‐resistant epilepsy is a long‐term conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaolong, Ou, Siqi, Zhang, Huaqiang, Zhen, Yuhang, Huang, Yinchun, Wei, Penghu, Shan, Yongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097058/
https://www.ncbi.nlm.nih.gov/pubmed/36929636
http://dx.doi.org/10.1002/brb3.2964
_version_ 1785024488067301376
author Wu, Xiaolong
Ou, Siqi
Zhang, Huaqiang
Zhen, Yuhang
Huang, Yinchun
Wei, Penghu
Shan, Yongzhi
author_facet Wu, Xiaolong
Ou, Siqi
Zhang, Huaqiang
Zhen, Yuhang
Huang, Yinchun
Wei, Penghu
Shan, Yongzhi
author_sort Wu, Xiaolong
collection PubMed
description BACKGROUND: Corpus callosotomy (CC) is appropriate for patients with seizures of a bilateral or diffuse origin, or those with seizures of a unilateral origin with rapid spread to the contralateral cerebral hemisphere. The efficiency of CC in patients with drug‐resistant epilepsy is a long‐term concern because most articles reporting the surgical results of CC arise from small case series, and the durations of follow‐up vary. METHODS: PubMed, Embase, Cochrane Library, and Web of Science were searched to identify papers published before November 8, 2021. The systematic review was completed following PRISMA guidelines. Outcomes were analyzed by meta‐analysis of the proportions. RESULTS: A total of 1644 patients with drug‐resistant epilepsy (49 retrospective or prospective case series studies) underwent CC, and the follow‐up time of all patients was at least 1 year. The rate of complete seizure freedom (SF) was 12.38% (95% confidence interval [CI], 8.17%–17.21%). Meanwhile, the rate of complete SF from drop attacks was 61.86% (95% CI, 51.87%–71.41%). The rates of complete SF after total corpus callosotomy (TCC) and anterior corpus callosotomy (ACC) were 11.41% (95% CI, 5.33%–18.91%) and 6.75% (95% CI, 2.76%–11.85%), respectively. Additionally, the rate of complete SF from drop attacks after TCC was significantly higher than that after ACC (71.52%, 95% CI, 54.22%–86.35% vs. 57.11%, 95% CI, 42.17%–71.49%). The quality of evidence for the three outcomes by GRADE assessment was low to moderate. CONCLUSION: There was no significant difference in the rate of complete SF between TCC and ACC. TCC had a significantly higher rate of complete SF from drop attacks than did ACC. Furthermore, CC for the treatment of drug‐resistant epilepsy remains an important problem for further investigation because there are no universally accepted standardized guidelines for the extent of CC and its benefit to patients. In future research, we will focus on this issue.
format Online
Article
Text
id pubmed-10097058
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100970582023-04-13 Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis Wu, Xiaolong Ou, Siqi Zhang, Huaqiang Zhen, Yuhang Huang, Yinchun Wei, Penghu Shan, Yongzhi Brain Behav Reviews BACKGROUND: Corpus callosotomy (CC) is appropriate for patients with seizures of a bilateral or diffuse origin, or those with seizures of a unilateral origin with rapid spread to the contralateral cerebral hemisphere. The efficiency of CC in patients with drug‐resistant epilepsy is a long‐term concern because most articles reporting the surgical results of CC arise from small case series, and the durations of follow‐up vary. METHODS: PubMed, Embase, Cochrane Library, and Web of Science were searched to identify papers published before November 8, 2021. The systematic review was completed following PRISMA guidelines. Outcomes were analyzed by meta‐analysis of the proportions. RESULTS: A total of 1644 patients with drug‐resistant epilepsy (49 retrospective or prospective case series studies) underwent CC, and the follow‐up time of all patients was at least 1 year. The rate of complete seizure freedom (SF) was 12.38% (95% confidence interval [CI], 8.17%–17.21%). Meanwhile, the rate of complete SF from drop attacks was 61.86% (95% CI, 51.87%–71.41%). The rates of complete SF after total corpus callosotomy (TCC) and anterior corpus callosotomy (ACC) were 11.41% (95% CI, 5.33%–18.91%) and 6.75% (95% CI, 2.76%–11.85%), respectively. Additionally, the rate of complete SF from drop attacks after TCC was significantly higher than that after ACC (71.52%, 95% CI, 54.22%–86.35% vs. 57.11%, 95% CI, 42.17%–71.49%). The quality of evidence for the three outcomes by GRADE assessment was low to moderate. CONCLUSION: There was no significant difference in the rate of complete SF between TCC and ACC. TCC had a significantly higher rate of complete SF from drop attacks than did ACC. Furthermore, CC for the treatment of drug‐resistant epilepsy remains an important problem for further investigation because there are no universally accepted standardized guidelines for the extent of CC and its benefit to patients. In future research, we will focus on this issue. John Wiley and Sons Inc. 2023-03-16 /pmc/articles/PMC10097058/ /pubmed/36929636 http://dx.doi.org/10.1002/brb3.2964 Text en © 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Wu, Xiaolong
Ou, Siqi
Zhang, Huaqiang
Zhen, Yuhang
Huang, Yinchun
Wei, Penghu
Shan, Yongzhi
Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title_full Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title_fullStr Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title_full_unstemmed Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title_short Long‐term follow‐up seizure outcomes after corpus callosotomy: A systematic review with meta‐analysis
title_sort long‐term follow‐up seizure outcomes after corpus callosotomy: a systematic review with meta‐analysis
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097058/
https://www.ncbi.nlm.nih.gov/pubmed/36929636
http://dx.doi.org/10.1002/brb3.2964
work_keys_str_mv AT wuxiaolong longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT ousiqi longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT zhanghuaqiang longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT zhenyuhang longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT huangyinchun longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT weipenghu longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis
AT shanyongzhi longtermfollowupseizureoutcomesaftercorpuscallosotomyasystematicreviewwithmetaanalysis